# AET05 variant 1 is produced correctly

    Code
      res
    Output
                                               Placebo        Xanomeline High Dose   Xanomeline Low Dose
                                               (N=86)                (N=84)                (N=84)       
      ——————————————————————————————————————————————————————————————————————————————————————————————————
      Total patient-years at risk                8.4                  15.7                   1.4        
      Number of adverse events observed          69                    79                    77         
      AE rate per 100 patient-years            819.32                502.87                5624.85      
      95% CI                              (626.00, 1012.64)     (391.98, 613.76)     (4368.49, 6881.21) 

# AET05 variant 2 is produced correctly

    Code
      res
    Output
                                               Placebo        Xanomeline High Dose   Xanomeline Low Dose
                                               (N=86)                (N=84)                (N=84)       
      ——————————————————————————————————————————————————————————————————————————————————————————————————
      Total patient-years at risk                8.4                  15.7                   1.4        
      Number of adverse events observed          69                    79                    77         
      AE rate per 100 patient-years            819.32                502.87                5624.85      
      95% CI                              (637.48, 1036.90)     (398.13, 626.73)     (4439.04, 7030.10) 

